
Granza Bio YC Application
Granza Bio went through Y Combinator in the Winter 2024 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2024
- Industry
- HealthcareTherapeutics
- Team size
- 7
- Status
- Active
- Launched
- 2024
Founders
Ashwin NandakumarFounder
Ashwin JainarayananFounder
What Granza Bio does
Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles - the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.
Granza Bio's YC application, reconstructed
Y Combinator application
Granza Bio, Winter 2024 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Granza Bio
Reprogramming Immunity for Targeted Medicines
We develop programmable immune therapeutics based on natural immune "superkiller" attack particles. Our platform re-arms exhausted immune cells with newly programmed ammunition, restoring their ability to attack diseases like cancer and autoimmunity specifically and effectively.
We live and work in San Francisco, CA, and plan to base the company here after YC.
San Francisco is the biotech and startup hub where we can access talent, partners, and investors necessary to build a new class of immune therapeutics.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Granza Bio YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Granza Bio's public data (launch notes, founder backgrounds, product description). It shows how a company like Granza Bio would present itself to YC, not the text they submitted.
What YC batch was Granza Bio in?
Granza Bio was part of the Y Combinator Winter 2024 batch.
Who founded Granza Bio?
Granza Bio was founded by Ashwin Nandakumar, Ashwin Jainarayanan.
What does Granza Bio do?
Reprogramming Immunity for Target-Specific Medicines
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Granza Bio's application, and every other YC batch, is in YC Insights.